Advertisement
Advertisement
U.S. markets close in 4 hours 32 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.0750-0.1650 (-7.37%)
As of 11:27AM EDT. Market open.
Advertisement
Full screen
Loading interactive chart...
  • Motley Fool

    2 Struggling Stocks to Avoid Right Now

    Many companies will rebound from the ongoing downturn as the economy improves, but in all likelihood, many others will continue to struggle. Many rushed to invest in companies such as Canopy Growth, which has long been considered one of the leaders in the field. Cannabis companies had trouble raising funds due to the nature of their business activities.

  • GlobeNewswire

    Vaxart to Present at the H.C. Wainwright 24th Annual Global Investment Conference

    SOUTH SAN FRANCISCO, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Andrei Floroiu, President and Chief Executive Officer, Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James Cummings, Chief Medical Officer, will be presenting virtually at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022. The pre-recorded presentation will be available on the Company’s Events page, accessible here: https:

  • GlobeNewswire

    Vaxart Announces Positive Top-line Phase II Clinical Study Data Demonstrating Safety and Immunogenicity of Its Wuhan S-Only COVID-19 Pill Vaccine Candidate

    — Study met primary safety and secondary immunogenicity endpoints — — Boosted serum neutralizing antibodies in both naive and previously mRNA vaccinated subjects — — Elicited cross-reactive mucosal responses in approximately 50% of subjects — — Company to host conference call at 8:30 a.m. ET today — SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today reported positive top-line data from the first part of a planned two-part Phase II study of its Wuhan

Advertisement
Advertisement